Haemophilus parahaemolyticus septic shock after aspiration pneumonia, France.
Anne-Sophie
AS
Le Floch
Nadim
N
Cassir
Sami
S
Hraiech
Christophe
C
Guervilly
Laurent
L
Papazian
Jean-Marc
JM
Rolain
D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005260:Female; D005602:France; D006190:Haemophilus / Q000235:genetics* / Q000302:isolation & purification; D006192:Haemophilus Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D006801:Humans; D008875:Middle Aged; D011015:Pneumonia, Aspiration / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D012128:Respiratory Distress Syndrome / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D012772:Shock, Septic / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents
France; Haemophilus parahaemolyticus; MALDI-TOF; bacteria; emerging pathogen; matrix-assisted laser desorption ionization time-of-flight; pneumonia; respiratory infections